Cited by 118Hyperglycemia and glycemic control in critically ill and hospitalized patientsDiabetes Management and ResearchDiabetes Treatment and Management

Comparison of basal-bolus and premixed insulin regimens in hospitalized patients with type 2 diabetes

Open access
Bellido, Virginia, Suarez, Lorena, Rodriguez, Maria Galiana, Sanchez, Cecilia, Dieguez, Marta, Riestra, Maria, Casal, Florentino, Delgado, Elias +2 more·2015·Diabetes Care

Abstract

OBJECTIVE: Premixed insulin is a commonly prescribed formulation for the outpatient management of patients with type 2 diabetes. The safety and efficacy of premixed insulin formulations in the hospital setting is not known. RESEARCH DESIGN AND METHODS: In a prospective, open-label trial, we randomized general medicine and surgery patients to receive a basal-bolus regimen with glargine once daily and glulisine before meals (n = 33) or premixed human insulin (30% regular insulin and 70% NPH insulin) twice daily (n = 39). Major outcomes included differences in daily blood glucose (BG) levels and frequency of hypoglycemic events (<70 mg/dL) between treatment groups. RESULTS: At the first prespecified interim analysis, the study was stopped early because of an increased frequency of hypoglycemia >50% in patients treated with premixed human insulin. A total of 64% of patients treated with premixed insulin experienced one or more episodes of hypoglycemia compared with 24% in the basal-bolus group (P < 0.001). There were no differences in mean daily BG level after the first day of insulin treatment (175 ± 32 vs. 179 ± 43 mg/dL, P = 0.64) between groups. A BG target between 80 and 180 mg/dL before meals was achieved in 55.9% of BG readings in the basal-bolus group and 54.3% of BG readings in the premixed insulin group (P = 0.23). There was no difference in the length of hospital stay or mortality between treatment groups. CONCLUSIONS: Inpatient treatment with premixed human insulin resulted in similar glycemic control but in significantly higher frequency of hypoglycemia compared with treatment with basal-bolus insulin regimen in hospitalized patients with diabetes.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.2337/dc15-0160

Cites

32 of 32 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • A prospective randomized inpatient study of 70/30 intermediate-acting (NPH)/regular insulin mixture versus basal-bolus therapy showed comparable glycemic outcomes but significantly increased hypoglycemia in the group receiving the insulin mixture.

    “A prospective randomized inpatient study of 70/30 intermediate-acting (NPH)/ regular insulin mixture versus basal-bolus therapy showed comparable glycemic outcomes but significantly increased hypoglycemia in the group receiving the insulin mixture (77).”
  • In a single-center RCT, correctional insulin sliding scales for bedtime hyperglycemia did not improve glycemic control in T2D patients.

    “In a single-center RCT, the use of correctional insulin sliding scales for bedtime hyperglycemia did not improve glycemic control in persons with T2D.1341,1342”

    From American Association of Clinical Endocrinology Clinical Practice Guideline: Developing a Diabetes Mellitus Comprehensive Care Plan-2022 Update. (2022) · cites this paper as [1341]

    The Insulin Treatment section describes randomization to basal-bolus or premixed insulin, not bedtime correctional sliding scales. The Conclusions report improved glycemic control with both regimens. Searches for bedtime correctional insulin and its effect on glycemic control found no passage addressing the claimed comparison; page numbers were unavailable in our copy. (LLM, conf=0.78)

    Experimental — accuracy not yet measured

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Research works printed but not linked: 1

  1. [25]25. Service FJ, Molnar GD, Rosevear JW, Ackerman E, Gatewood LC, Taylor WF. Mean am- plitude of glycemic excursions, a measure of di- abetic instability. Diabetes 1970;19:644-655

Cited by

Sorted by citations

Authors
Bellido, V., Suarez, L., Rodriguez, M. G., Sanchez, C., Dieguez, M., Riestra, M., Casal, F., Delgado, E., Menendez, E., & Umpierrez, G. E.
Affiliations
  • Hospital Universitario Central de Asturias (ES)
  • Hospital Universitario Central de Asturias, Oviedo, Asturias, Spain
  • Hospital de Cabueñes, Gijón, Asturias, Spain
  • Hospital Universitario De Cabueñes (ES)
  • Emory University (US)
Corresponding author
Bellido, Virginia
Venue
Diabetes Care
Published
2015-10-12
Volume
38
Issue
12
Pages
2211-2216
ISSN
  • 0149-5992 (ISSN-L)
  • 1935-5548
OpenAlex
W2177119636
Cited by
118
References
32
Citations by year
2026: 2 · 2025: 12 · 2024: 11 · 2023: 8 · 2022: 13 · 2021: 18 · 2020: 14 · 2019: 7 · 2018: 16 · 2017: 12 · 2016: 4 · 2015: 1
FWCI
9.56
Type
journal article
Language
en
Open access
Locations
  • Diabetes Care (publishedVersion)
  • PubMed Central (publishedVersion)
  • PubMed (publishedVersion)
Funders
Sanofi Aventis
Topics
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Hyperglycemia and glycemic control in critically ill and hospitalized patients
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Treatment and Management
Keywords
type 2 diabetes, premixed insulin, multiple daily insulin injections, hospitalized patients, hypoglycemia, glycemic control, glargine, glulisine, NPH insulin, blood glucose
MeSH terms
Insulin Glargine, Aged, Blood Glucose, Diabetes Mellitus, Type 2, Drug Combinations, Female, Hospitalization, Humans, Hypoglycemia, Hypoglycemic Agents, Insulin, Insulin, Isophane, Male, Middle Aged, Prospective Studies, Insulin, Regular, Human

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review